Nothing
#' finalfit: Quickly create elegant final results tables and plots when modelling.
#'
#' @description Quickly create elegant final results tables and plots when modelling.
#'
#' @section \code{finalfit} model wrappers:
#'
#' \link{glmuni},
#' \link{glmmulti},
#' \link{glmmulti_boot},
#' \link{glmmixed},
#' \link{lmuni},
#' \link{lmmulti},
#' \link{lmmixed},
#' \link{coxphuni},
#' \link{coxphmulti},
#' \link{crruni},
#' \link{crrmulti},
#' \link{svyglmuni},
#' \link{svyglmmulti}.
#'
#' @section \code{finalfit} model extractor:
#'
#' Generic:
#' \link{fit2df}
#'
#' Methods (not called directly):
#' \link{fit2df.glm},
#' \link{fit2df.glmlist},
#' \link{fit2df.glmboot},
#' \link{fit2df.lm},
#' \link{fit2df.lmlist},
#' \link{fit2df.glmerMod},
#' \link{fit2df.lmerMod},
#' \link{fit2df.coxph},
#' \link{fit2df.coxphlist},
#' \link{fit2df.crr},
#' \link{fit2df.crrlist},
#' \link{fit2df.stanfit}.
#'
#' @section \code{finalfit} all-in-one function:
#'
#' Generic:
#' \link{finalfit}.
#' \link{finalfit_permute}.
#'
#' Methods (not called directly):
#' \link{finalfit.glm},
#' \link{finalfit.lm},
#' \link{finalfit.coxph}.
#'
#' @section \code{finalfit} plotting functions:
#'
#' \link{coefficient_plot},
#' \link{or_plot},
#' \link{hr_plot},
#' \link{surv_plot},
#' \link{ff_plot}.
#'
#' @section \code{finalfit} helper functions:
#'
#' \link{ff_glimpse},
#' \link{ff_label},
#' \link{ff_merge},
#' \link{ff_interaction}.
#'
#' @section \code{finalfit} prediction functions:
#'
#' \link{boot_predict},
#' \link{finalfit_newdata}.
#'
#' Methods (not called directly):
#' \link{boot_compare}.
#'
#' @section \code{finalfit} missing data functions:
#'
#' \link{missing_glimpse},
#' \link{missing_pattern},
#' \link{missing_compare},
#' \link{missing_plot},
#' \link{missing_pairs}.
#'
#' @docType package
#' @name finalfit-package
#'
#' @importFrom stats as.formula formula coef confint confint.default glm lm logLik pnorm
#' quantile setNames model.matrix terms
# @exportPattern ^[[:alpha:]]+
NULL
#' Pipe operator
#'
#' @name %>%
#' @rdname pipe
#' @keywords internal
#' @importFrom dplyr %>%
#' @usage lhs \%>\% rhs
#' @export
NULL
#' magrittr compound assignment pipe-operator
#'
#' @name %<>%
#' @rdname compoundpipe
#' @keywords internal
#' @importFrom magrittr %<>%
#' @usage lhs \%<>\% rhs
#' @export
NULL
#' magrittr exposition pipe-operator
#'
#' @name %$%
#' @rdname expositionpipe
#' @keywords internal
#' @importFrom magrittr %$%
#' @usage lhs \%$\% rhs
#' @export
NULL
#' Chemotherapy for Stage B/C colon cancer
#'
#' This is a modified version of \code{survival::\link[survival]{colon}}.These
#' are data from one of the first successful trials of adjuvant chemotherapy for
#' colon cancer. Levamisole is a low-toxicity compound previously used to treat
#' worm infestations in animals; 5-FU is a moderately toxic (as these things go)
#' chemotherapy agent. There are two records per person, one for recurrence and
#' one for death
#'
#' @name colon_s
#'
#' @format A data frame with 929 rows and 33 variables
#' @source \code{\link[survival]{colon}}
#' @docType data
#' @usage data(colon_s)
#' @keywords data
NULL
#' Western Collaborative Group Study
#'
#' 3154 healthy young men aged 39-59 from the San Francisco area were assessed
#' for their personality type. All were free from coronary heart disease at the
#' start of the research. Eight and a half years later change in this situation
#' was recorded.
#'
#' The WCGS began in 1960 with 3,524 male volunteers who were employed by 11
#' California companies. Subjects were 39 to 59 years old and free of heart
#' disease as determined by electrocardiogram. After the initial screening, the
#' study population dropped to 3,154 and the number of companies to 10 because
#' of various exclusions. The cohort comprised both blue- and white-collar
#' employees. At baseline the following information was collected:
#' socio-demographic including age, education, marital status, income,
#' occupation; physical and physiological including height, weight, blood
#' pressure, electrocardiogram, and corneal arcus; biochemical including
#' cholesterol and lipoprotein fractions; medical and family history and use of
#' medications; behavioral data including Type A interview, smoking, exercise,
#' and alcohol use. Later surveys added data on anthropometry, triglycerides,
#' Jenkins Activity Survey, and caffeine use. Average follow-up continued for
#' 8.5 years with repeat examinations
#'
#' @name wcgs
#'
#' @format A data frame with 3154 observations on the following 13 variables.
#' \describe{ \item{\code{id}}{ Subject ID } \item{\code{age}}{ Age: age in
#' years } \item{\code{height}}{ Height: height in inches }
#' \item{\code{weight}}{ Weight: weight in pounds } \item{\code{sbp}}{
#' Systolic blood pressure: mmHg } \item{\code{dbp}}{ Diastolic blood
#' pressure: mmHg } \item{\code{chol}}{ Cholesterol: mg/100 ml }
#' \item{\code{personality}}{Personality type/Behavior pattern: a factor with
#' levels \code{A1}, \code{A2}, \code{B3}, \code{B4} }
#' \item{\code{personality_2L}}{ Dichotomous personality type / behavior
#' pattern: \code{A} = aggressive; \code{B} = passive } \item{\code{ncigs}}{
#' Smoking: Cigarettes/day } \item{\code{smoking}}{ Smoking: \code{No},
#' \code{Yes} } \item{\code{arcus}}{ Corneal arcus: \code{No}, \code{Yes} }
#' \item{\code{chd}}{ Coronary heart disease event: \code{No} \code{Yes}}
#' \item{\code{typechd}}{ coronary heart disease is a factor with levels
#' \code{No}, \code{MI_SD} (MI or sudden death), \code{Silent_MI},
#' \code{Angina} } \item{\code{timechd}}{ Observation (follow up) time: Days }
#' }
#' @source Statistics for Epidemiology by N. Jewell (2004)
#' @references Coronary Heart Disease in the Western Collaborative Group Study
#' Final Follow-up Experience of 8 1/2 Years Ray H. Rosenman, MD; Richard J.
#' Brand, PhD; C. David Jenkins, PhD; Meyer Friedman, MD; Reuben Straus, MD;
#' Moses Wurm, MD JAMA. 1975;233(8):872-877.
#' doi:10.1001/jama.1975.03260080034016.
#' @docType data
#' @usage data(wcgs)
#' @keywords data
NULL
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.